2022-11-24 18:45:00

Liquid Biopsy Global Market to Reach $15.01 Billion by 2026 at a 30.6% CAGR

Logo PR Newswire
PR Newswire

DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Liquid Biopsy Global Market Report 2022, By Product, By End User, By Clinical Application" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global liquid biopsy market is expected to grow from $4.02 billion in 2021 to $5.17 billion in 2022 at a compound annual growth rate (CAGR) of 28.5%. The market is expected to reach $15.01 billion in 2026 at a CAGR of 30.6%.

Government funds for refining cancer detection drive the growth of the liquid biopsy market. Government funds help researchers in drug discovery, diagnosis, and treatment of diseases such as Cancer. For instance, in 2019, National Cancer Institute (NCI), a USA-based government agency gave funds worth $2.1 million and a five-year grant to Translational Genomics Research Institute (TGen), a genomics research institute based in U.S.A.

The funding enables TGen and Mayo Clinic researchers to drive the clinical trials for liquid biopsy test for the detection of breast cancer. The National Cancer Institute (NCI) aims to post a Funding Opportunity Announcement (FOA) in December 2020 to enable applications for cancer diagnosis, prevention, identification and treatment innovations for public health (U01 activity code). The FAO has projected that the overall funding is expected to hit $4 million in the fiscal year 2022. Therefore, government funds positively impact the growth of liquid biopsy market.

Unclear regulations on laboratory developed tests (LDT) for liquid biopsy have always been a major challenge in the liquid biopsy market. A laboratory developed test (LDT) is an in-vitro diagnostic test (IVD) intended for clinical use that is designed, manufactured to be used in a single laboratory. For instance, in 2019, the Food and Drug Administration (FDA) proposed a plan to increase the regulations for the approval of laboratory developed tests.

However, the regulations are unclear and do not reduce the time it takes for the approval of these tests. Following this, the FDA, till 2019, has approved only two liquid biopsy tests. The first test which identifies EGFR mutations in NSCLC patients was approved in 2016 while the second test for detecting the PIK3CA mutation in patients was approved in 2019. Such delays in the approval of liquid biopsy tests by the FDA are expected to have a negative impact on the liquid biopsy market.

Companies are rapidly adopting new market dynamics and focusing primarily on new product launches, to meet the ever-increasing need for liquid biopsy products and services, to increase their revenue and also for gaining a competitive edge over their rivals.

For instance, In August 2020, Personalis, Inc., a USA based advanced cancer genomics company, revealed the introduction of NeXT Liquid Biopsy, a high-performance, exome-scale, tumor-profiling device that uses blood samples from innovative solid tumour cancer patients. NeXT Liquid Biopsy, combined with Personalis' leading immunoid NeXT tissue profiling tool, allows a more detailed immuno-genomics image of the tumour which can now be tracked over time from blood samples.

These abilities can enable biopharmaceutical businesses improve their knowledge of tumour biology, specifically resistance mechanisms, to help create next-generation cancer therapies. Thus, companies are investing in the development of new products in the liquid biopsy market.


Markets Covered:
1) By Technique: Ultrasound; MRI; X-ray; Computed Tomography; Others
2) By Application: Oncology; Cardiology; Orthopedic; Others
3) By End User: Diagnostic Centers; Hospitals; Research Centers

Key Topics Covered:

1. Executive Summary

2. Liquid Biopsy Market Characteristics

3. Liquid Biopsy Market Trends And Strategies

4. Impact Of COVID-19 On Liquid Biopsy

5. Liquid Biopsy Market Size And Growth

6. Liquid Biopsy Market Segmentation

7. Liquid Biopsy Market Regional And Country Analysis

8. Asia-Pacific Liquid Biopsy Market

9. China Liquid Biopsy Market

10. India Liquid Biopsy Market

11. Japan Liquid Biopsy Market

12. Australia Liquid Biopsy Market

13. Indonesia Liquid Biopsy Market

14. South Korea Liquid Biopsy Market

15. Western Europe Liquid Biopsy Market

16. UK Liquid Biopsy Market

17. Germany Liquid Biopsy Market

18. France Liquid Biopsy Market

19. Eastern Europe Liquid Biopsy Market

20. Russia Liquid Biopsy Market

21. North America Liquid Biopsy Market

22. USA Liquid Biopsy Market

23. South America Liquid Biopsy Market

24. Brazil Liquid Biopsy Market

25. Middle East Liquid Biopsy Market

26. Africa Liquid Biopsy Market

27. Liquid Biopsy Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Liquid Biopsy Market

29. Liquid Biopsy Market Future Outlook and Potential Analysis

30. Appendix

Companies Mentioned

  • Qiagen N.V.
  • Roche Diagnostics
  • Bio-Rad Laboratories Inc.
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Thermo Fisher Scientific
  • Guardant Health
  • Menarini Silicon Biosystems
  • Biocept Inc.
  • F. Hoffmann-La Roche AG
  • Janssen Diagnostics LLC.
  • Trovagene Inc.
  • Fraunhofer-Gesellschaft
  • MDX Health SA
  • Agilent Technologies Inc.
  • Cygnus Biosciences
  • Illumina Inc.
  • Oxford Nanopore
  • Quantum Biosystems

For more information about this report visit https://www.researchandmarkets.com/r/8sljgx

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/liquid-biopsy-global-market-to-reach-15-01-billion-by-2026-at-a-30-6-cagr-301686934.html

SOURCE Research and Markets

Logo PR Newswire
HealthPress Release2022-11-15 16:00:00
CHICAGO, Nov. 15, 2022 /PRNewswire/ -- Liquid Biopsy Market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3%...

Logo GlobeNewswire
EconomyPress Release2022-11-10 07:29:00
The increasing demand for non-invasive disease diagnosis and continuous product launches with a high focus on R&D by top market players are helping to...

Logo PR Newswire
DUBLIN, Nov. 8, 2022 /PRNewswire/ -- The "Global Liquid Biopsy Market By Offering, By Technology, Next Generation Sequencing, By Workflow, By Sample, By...

Logo EIN Presswire
HealthPress Release2022-11-18 13:55:44
NEWARK, UNITED STATES, November 18, 2022 / EINPresswire.com / -- A recent research report published by The Brainy Insights on the Global Liquid Biopsy market...

Logo EIN Presswire
HealthPress Release2022-10-28 10:36:59
Breast Cancer Liquid Biopsy Size, Growth, Trends and Forecast (2022-2031) The Breast Cancer Liquid Biopsy Market size was estimated at USD 87.71 mn in 2021,...

Logo EIN Presswire
Increase in the prevalence of cancer, advent of novel & minimally invasive biopsy & rise in public awareness for disease screening fuel PORTLAND,...

Logo EIN Presswire
HealthPress Release2022-11-11 13:30:00
Market Research Reports, Business Consulting Services & Analytics Increasing Advancement in the Treatment of Prostate Cancer and Rising Advancement in...

Logo PR Newswire
HealthPress Release2022-11-07 14:15:00
DUBLIN, Nov. 7, 2022 /PRNewswire/ -- The "Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report...

Logo PR Newswire
HealthPress Release2022-11-18 19:30:00
DUBLIN, Nov. 18, 2022 /PRNewswire/ -- The "Global Precision Medicine Market By Type, By Application, By End-use & By Region Forecast and Analysis...

Logo EIN Presswire
SciencePress Release2022-11-10 14:09:15
In-vitro Diagnostics Market 2022-2027 LONDON, UK, November 10, 2022 / EINPresswire.com / -- The in-vitro diagnostics market size reached USD 95.30 billion in...

Logo EIN Presswire
HealthPress Release2022-11-10 12:41:27
Emergen Research Logo Rising occurrences of target conditions and advancements in biomedical technology are among the significant factors influencing market...

Logo PR Newswire
HealthPress Release2022-11-15 21:15:00
DUBLIN, Nov. 15, 2022 /PRNewswire/ -- The "Biosimilars Global Market Report 2022: By Product, By Types, By Application" report has been added to...

Logo PR Newswire
HealthPress Release2022-11-01 12:15:00
PUNE, India, Nov. 1, 2022 /PRNewswire/ -- Maximize Market Research has published a report on the Microscopy Market that provides a detailed analysis for the...

Logo EIN Presswire
HealthPress Release2022-11-01 04:58:17
Global Biopsy System Market size Biopsy System Market Size And Forecast 2022 to 2031 | Hologic, Siemens, Invivo, Planmed, METALTRONICA, Hologic NEW YORK...

Logo EIN Presswire
HealthPress Release2022-10-31 11:30:48
Breast Biopsy System Market size Breast Biopsy System Market Size study, by Product Type, By Application, and Regional Forecasts 2022-2030 NEW YORK CITY, NEW...

Logo Benzinga
Business / FinanceBy Pr Newswire2022-10-31 15:30:00
As per DelveInsight analysis in the biologics market, the growing prevalence diseases of various etiologies such as autoimmune disorders, infectious...

Logo PR Newswire
HealthPress Release2022-10-31 15:30:00
As per DelveInsight analysis in the biologics market, the growing prevalence diseases of various etiologies such as autoimmune disorders, infectious...

Logo EIN Presswire
HealthPress Release2022-11-04 13:15:00
Market Research Reports, Business Consulting Services & Analytics Increasing Predominance Of Chronic Diseases Around The World Is Fueling The Growth Of...

Logo PR Newswire
HealthPress Release2022-11-22 10:30:00
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- The "Global Biosimilars Market, By Indication Type, By Product & By Region- Forecast and Analysis 2022-2028" report...

Logo EIN Presswire
Digital Pathology Market PORTLAND, OR, UNITED STATES, November 8, 2022 / EINPresswire.com / -- According to the report published by Allied Market Research,...